Previous exposure to (±) 3,4-methylenedioxymethamphetamine produces long-lasting alteration in limbic brain excitability measured by electroencephalogram spectrum analysis, brain metabolism and seizure susceptibility

F. S. Giorgi, C. Pizzanelli, M. Ferrucci, G. Lazzeri, M. Faetti, M. Giusiani, F. Pontarelli, C. L. Busceti, L. Murri, F. Fornai

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Seizures represent the most common neurological emergency in ecstasy abusers; however, no study addressed whether (±) 3,4- methylenedioxymethamphetamine ("ecstasy") per se might produce long-lasting alterations in brain excitability related to a pro-convulsant effect. C57Black mice were treated with three regimens of (±) 3,4-methylenedioxymethamphetamine (5mg/kg×2 for 1, 2 or three consecutive days). Following the last dose of (±) 3,4-methylenedioxymethamphetamine, during a time interval of 8 weeks, the following procedures were carried out: 1) cortical electroencephalographic recordings, including power-spectrum analysis; 2) administration of sub-threshold doses of kainate; 3) measurement of regional [14C]2-deoxyglucose uptake; 4) monoamine assay. We demonstrate that all mice pre-treated with (±) 3,4-methylenedioxymethamphetamine showed long-lasting encephalographic changes with frequencies peaking at 3-4.5Hz at the power-spectrum analysis. This is concomitant with latent brain hyperexcitability within selected limbic brain regions, as shown by seizure facilitation and long-lasting latent metabolic hyperactivity which can be unraveled by phasic glutamate stimulation. This study sheds new light into the brain targets of (±) 3,4-methylenedioxymethamphetamine and discloses the occurrence of (±) 3,4-methylenedioxymethamphetamine-induced latent hyperexcitability within limbic areas, while it might provide a model to study in controlled experimental conditions limbic seizures and status epilepticus in C57Black mice. Persistent changes produced by (±) 3,4- methylenedioxymethamphetamine in limbic brain excitability might be responsible for seizures and limbic-related disorders in chronic (±) 3,4-methylenedioxymethamphetamine abusers.

Original languageEnglish
Pages (from-to)43-53
Number of pages11
JournalNeuroscience
Volume136
Issue number1
DOIs
Publication statusPublished - 2005

Fingerprint

N-Methyl-3,4-methylenedioxyamphetamine
Electroencephalography
Spectrum Analysis
Seizures
Brain
Convulsants
Status Epilepticus
Kainic Acid
Deoxyglucose
Glutamic Acid
Emergencies

Keywords

  • [ C]2-DG
  • Ecstasy
  • EEG synchronization
  • Epilepsy
  • Kainate
  • Limbic epilepsy

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Previous exposure to (±) 3,4-methylenedioxymethamphetamine produces long-lasting alteration in limbic brain excitability measured by electroencephalogram spectrum analysis, brain metabolism and seizure susceptibility. / Giorgi, F. S.; Pizzanelli, C.; Ferrucci, M.; Lazzeri, G.; Faetti, M.; Giusiani, M.; Pontarelli, F.; Busceti, C. L.; Murri, L.; Fornai, F.

In: Neuroscience, Vol. 136, No. 1, 2005, p. 43-53.

Research output: Contribution to journalArticle

@article{0c6bf864c30f4e38bb3096d646805476,
title = "Previous exposure to (±) 3,4-methylenedioxymethamphetamine produces long-lasting alteration in limbic brain excitability measured by electroencephalogram spectrum analysis, brain metabolism and seizure susceptibility",
abstract = "Seizures represent the most common neurological emergency in ecstasy abusers; however, no study addressed whether (±) 3,4- methylenedioxymethamphetamine ({"}ecstasy{"}) per se might produce long-lasting alterations in brain excitability related to a pro-convulsant effect. C57Black mice were treated with three regimens of (±) 3,4-methylenedioxymethamphetamine (5mg/kg×2 for 1, 2 or three consecutive days). Following the last dose of (±) 3,4-methylenedioxymethamphetamine, during a time interval of 8 weeks, the following procedures were carried out: 1) cortical electroencephalographic recordings, including power-spectrum analysis; 2) administration of sub-threshold doses of kainate; 3) measurement of regional [14C]2-deoxyglucose uptake; 4) monoamine assay. We demonstrate that all mice pre-treated with (±) 3,4-methylenedioxymethamphetamine showed long-lasting encephalographic changes with frequencies peaking at 3-4.5Hz at the power-spectrum analysis. This is concomitant with latent brain hyperexcitability within selected limbic brain regions, as shown by seizure facilitation and long-lasting latent metabolic hyperactivity which can be unraveled by phasic glutamate stimulation. This study sheds new light into the brain targets of (±) 3,4-methylenedioxymethamphetamine and discloses the occurrence of (±) 3,4-methylenedioxymethamphetamine-induced latent hyperexcitability within limbic areas, while it might provide a model to study in controlled experimental conditions limbic seizures and status epilepticus in C57Black mice. Persistent changes produced by (±) 3,4- methylenedioxymethamphetamine in limbic brain excitability might be responsible for seizures and limbic-related disorders in chronic (±) 3,4-methylenedioxymethamphetamine abusers.",
keywords = "[ C]2-DG, Ecstasy, EEG synchronization, Epilepsy, Kainate, Limbic epilepsy",
author = "Giorgi, {F. S.} and C. Pizzanelli and M. Ferrucci and G. Lazzeri and M. Faetti and M. Giusiani and F. Pontarelli and Busceti, {C. L.} and L. Murri and F. Fornai",
year = "2005",
doi = "10.1016/j.neuroscience.2005.07.036",
language = "English",
volume = "136",
pages = "43--53",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Previous exposure to (±) 3,4-methylenedioxymethamphetamine produces long-lasting alteration in limbic brain excitability measured by electroencephalogram spectrum analysis, brain metabolism and seizure susceptibility

AU - Giorgi, F. S.

AU - Pizzanelli, C.

AU - Ferrucci, M.

AU - Lazzeri, G.

AU - Faetti, M.

AU - Giusiani, M.

AU - Pontarelli, F.

AU - Busceti, C. L.

AU - Murri, L.

AU - Fornai, F.

PY - 2005

Y1 - 2005

N2 - Seizures represent the most common neurological emergency in ecstasy abusers; however, no study addressed whether (±) 3,4- methylenedioxymethamphetamine ("ecstasy") per se might produce long-lasting alterations in brain excitability related to a pro-convulsant effect. C57Black mice were treated with three regimens of (±) 3,4-methylenedioxymethamphetamine (5mg/kg×2 for 1, 2 or three consecutive days). Following the last dose of (±) 3,4-methylenedioxymethamphetamine, during a time interval of 8 weeks, the following procedures were carried out: 1) cortical electroencephalographic recordings, including power-spectrum analysis; 2) administration of sub-threshold doses of kainate; 3) measurement of regional [14C]2-deoxyglucose uptake; 4) monoamine assay. We demonstrate that all mice pre-treated with (±) 3,4-methylenedioxymethamphetamine showed long-lasting encephalographic changes with frequencies peaking at 3-4.5Hz at the power-spectrum analysis. This is concomitant with latent brain hyperexcitability within selected limbic brain regions, as shown by seizure facilitation and long-lasting latent metabolic hyperactivity which can be unraveled by phasic glutamate stimulation. This study sheds new light into the brain targets of (±) 3,4-methylenedioxymethamphetamine and discloses the occurrence of (±) 3,4-methylenedioxymethamphetamine-induced latent hyperexcitability within limbic areas, while it might provide a model to study in controlled experimental conditions limbic seizures and status epilepticus in C57Black mice. Persistent changes produced by (±) 3,4- methylenedioxymethamphetamine in limbic brain excitability might be responsible for seizures and limbic-related disorders in chronic (±) 3,4-methylenedioxymethamphetamine abusers.

AB - Seizures represent the most common neurological emergency in ecstasy abusers; however, no study addressed whether (±) 3,4- methylenedioxymethamphetamine ("ecstasy") per se might produce long-lasting alterations in brain excitability related to a pro-convulsant effect. C57Black mice were treated with three regimens of (±) 3,4-methylenedioxymethamphetamine (5mg/kg×2 for 1, 2 or three consecutive days). Following the last dose of (±) 3,4-methylenedioxymethamphetamine, during a time interval of 8 weeks, the following procedures were carried out: 1) cortical electroencephalographic recordings, including power-spectrum analysis; 2) administration of sub-threshold doses of kainate; 3) measurement of regional [14C]2-deoxyglucose uptake; 4) monoamine assay. We demonstrate that all mice pre-treated with (±) 3,4-methylenedioxymethamphetamine showed long-lasting encephalographic changes with frequencies peaking at 3-4.5Hz at the power-spectrum analysis. This is concomitant with latent brain hyperexcitability within selected limbic brain regions, as shown by seizure facilitation and long-lasting latent metabolic hyperactivity which can be unraveled by phasic glutamate stimulation. This study sheds new light into the brain targets of (±) 3,4-methylenedioxymethamphetamine and discloses the occurrence of (±) 3,4-methylenedioxymethamphetamine-induced latent hyperexcitability within limbic areas, while it might provide a model to study in controlled experimental conditions limbic seizures and status epilepticus in C57Black mice. Persistent changes produced by (±) 3,4- methylenedioxymethamphetamine in limbic brain excitability might be responsible for seizures and limbic-related disorders in chronic (±) 3,4-methylenedioxymethamphetamine abusers.

KW - [ C]2-DG

KW - Ecstasy

KW - EEG synchronization

KW - Epilepsy

KW - Kainate

KW - Limbic epilepsy

UR - http://www.scopus.com/inward/record.url?scp=26944444296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26944444296&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2005.07.036

DO - 10.1016/j.neuroscience.2005.07.036

M3 - Article

VL - 136

SP - 43

EP - 53

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 1

ER -